Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

634 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High-dose local irradiation plus prophylactic hepatic irradiation and chemotherapy for inoperable adenocarcinoma of the pancreas. A preliminary report of a multi-institutional trial (Radiation Therapy Oncology Group Protocol 8801).
Komaki R, Wadler S, Peters T, Byhardt RW, Order S, Gallagher MJ, Herskovic A, Pederson J. Komaki R, et al. Cancer. 1992 Jun 1;69(11):2807-12. doi: 10.1002/1097-0142(19920601)69:11<2807::aid-cncr2820691128>3.0.co;2-o. Cancer. 1992. PMID: 1571912 Clinical Trial.
Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer.
Sause WT, Scott C, Taylor S, Johnson D, Livingston R, Komaki R, Emami B, Curran WJ, Byhardt RW, Turrisi AT, et al. Sause WT, et al. Among authors: komaki r. J Natl Cancer Inst. 1995 Feb 1;87(3):198-205. doi: 10.1093/jnci/87.3.198. J Natl Cancer Inst. 1995. PMID: 7707407 Clinical Trial.
Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: failure patterns by cell type in RTOG 88-08/ECOG 4588. Radiation Therapy Oncology Group. Eastern Cooperative Oncology Group.
Komaki R, Scott CB, Sause WT, Johnson DH, Taylor SG 4th, Lee JS, Emami B, Byhardt RW, Curran WJ Jr, Dar AR, Cox JD. Komaki R, et al. Int J Radiat Oncol Biol Phys. 1997 Oct 1;39(3):537-44. doi: 10.1016/s0360-3016(97)00365-9. Int J Radiat Oncol Biol Phys. 1997. PMID: 9336129 Clinical Trial.
Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer.
Roth JA, Atkinson EN, Fossella F, Komaki R, Bernadette Ryan M, Putnam JB Jr, Lee JS, Dhingra H, De Caro L, Chasen M, Hong WK. Roth JA, et al. Among authors: komaki r. Lung Cancer. 1998 Jul;21(1):1-6. doi: 10.1016/s0169-5002(98)00046-4. Lung Cancer. 1998. PMID: 9792048 Clinical Trial.
The benefit of treatment intensification is age and histology-dependent in patients with locally advanced non-small cell lung cancer (NSCLC): a quality-adjusted survival analysis of radiation therapy oncology group (RTOG) chemoradiation studies.
Movsas B, Scott C, Sause W, Byhardt R, Komaki R, Cox J, Johnson D, Lawton C, Dar AR, Wasserman T, Roach M, Lee JS, Andras E. Movsas B, et al. Among authors: komaki r. Int J Radiat Oncol Biol Phys. 1999 Dec 1;45(5):1143-9. doi: 10.1016/s0360-3016(99)00325-9. Int J Radiat Oncol Biol Phys. 1999. PMID: 10613306 Clinical Trial.
Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group.
Sause W, Kolesar P, Taylor S IV, Johnson D, Livingston R, Komaki R, Emami B, Curran W Jr, Byhardt R, Dar AR, Turrisi A 3rd. Sause W, et al. Among authors: komaki r. Chest. 2000 Feb;117(2):358-64. doi: 10.1378/chest.117.2.358. Chest. 2000. PMID: 10669675 Clinical Trial.
634 results